Abstract
A new scheme for refractive measurements under atropine cycloplegia was tested in 90 strabismic children aged two to several years. Refraction was determined by an autorefractor (CANON R 10) 90 minutes after application of two drops of atropine (0.5% atropine children <21/2 years; 1.0% atropine children >21/2 years) and compared with the results after 3 days of receiving 1 atropine eyedrop 3 times daily. In 86.5% the spherical equivalents differ not more than 1.0 diopter (p = 0.05); the correlation was 0.99. Astigmatic corrections were in agreement in 95.5%, the axis of cylinders in 93.0% (p = 0.05); the correlations were 0.95 and 0.97. The residual accommodation 90 minutes after 2 drops of atropine was not more than 1 diopter in all children. The additional cycloplegic effect of the three-day-atropinization was only 0.5 diopters. This new type of application allows a more rapid and less toxic assessment of refraction than the usual three-day-atropinization.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Duke-Elder WS. The practice of refraction. Philadelphia: Blakiston, 1943.
German ME, Siddiqui N. Atropine toxicity from eyedrops. N Engl Med J 1970; 282: 689.
Joos HA. Atropine intoxication in infancy. Am J Dis Child 1950; 79: 855–861.
O'Connor PS, Mumma JV. Atropine toxicity. Am J Ophthalmol 1985; 99: 613–614.
Heath WE. Death from atropine poisoning. Br Med J 1950; 9: 608.
Safir A, Hayms L, Philpot I, Jagerman LS. Studies in refraction, I: The precision of retinoscopy. Arch Ophthalmol 1971; 84: 46–61.
Rassow B, Wesemann W. Moderne Autorefraktometer. Stuttgart: Enke Verlag, 1984: 33–39.
Rassow B, Wesemann W. Automatic infrared refractors. Ophthalmology 1985; 92: 20–33.
Duke-Elder WS, Abrams D. Ophthalmic optics and refraction. In Duke-Elder S, ed. System of ophthalmology, Vol 5. London: Henry Kimpton, 1970: 476.
Beitel RJ. Cycloplegic refraction. In Duane TD, Jaeger EA, eds. Clinical ophthalmology. Philadelphia: Harper & Row, 1982: 1–4.
Amos DM. Cycloplegic refraction. In Bartlett JD, Jaenus SD, eds. Clinical ocular pharmacology. Boston: Butterworth, 1984: 469–481.
Ingram RM, Barr. Refraction of 1-year-old children after cycloplegia with 1% cyclopentolate: Comparison with findings after atropinization. Br J Ophth 1979; 63: 348–352.
Rosenbaum AL, Bateman JB, Bremer DL, Liu PY. Cycloplegic refraction in esotropic children. Ophthalmologica 1981; 88: 1031–1034.
Priestley BS, Medine MM. A new mydriatic and cycloplegic drug. Am J Ophthalmol 1951; 34: 572–575.
Binkhorst RD, Weinstein GW, Baretz RM, Clahane AC. Psychotic reaction induced by cyclopentolate (Cyclogyl). Am J Ophthalmol 1963; 55: 1243–1245.
Simcoe CW. Cyclopentolate (cyclogyl) toxicity. Arch Ophthalmol 1962; 67: 406–408.
Kennerdell JS, Wucher FP. Cyclopentolate associated with two cases or grand mal seizure. Arch ophthalmol 1972; 87: 634–635.
Zetterström C. A cross-over study of the cycloplegic effects of a single topical application of cyclopentolate-phenylephrine and routine atropinization for 3.5 days. Acta Ophthalmologika 1985; 63: 525–529.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Auffarth, G., Hunold, W. Cycloplegic refraction in children: Single-dose-atropinization versus three-day-atropinization. Doc Ophthalmol 80, 353–362 (1992). https://doi.org/10.1007/BF00154384
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00154384